RFM/CPAP sub-group intervention study
OSA, cardiovascular disease, CRAE, CRVE
HYPERCHOLESTEROLEMIA, HYPERTENSION, CARDIOVASCULAR DISEASE
This section describes results for the 12 month RFM/CPAP interventional study (n = 66) which aimed to evaluate whether stabilising known cardiovascular disease risk factors (hypertension, hypercholesterolemia), while concurrently treating OSA with continuous positive airway pressure (CPAP), would result in alterations in evening CRAE, CRVE and overnight change in CRAE and CRVE.